Compare DAN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAN | STVN |
|---|---|---|
| Founded | 1904 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.7B |
| IPO Year | 2002 | 2021 |
| Metric | DAN | STVN |
|---|---|---|
| Price | $27.08 | $19.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $40.60 | $25.67 |
| AVG Volume (30 Days) | ★ 1.6M | 267.4K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.34% | 0.39% |
| EPS Growth | ★ 264.10 | N/A |
| EPS | ★ 9.89 | N/A |
| Revenue | ★ $7,500,000,000.00 | N/A |
| Revenue This Year | $1.89 | $9.67 |
| Revenue Next Year | $4.59 | $9.99 |
| P/E Ratio | ★ $2.79 | $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.31 | $12.89 |
| 52 Week High | $39.56 | $28.00 |
| Indicator | DAN | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 44.18 | 57.51 |
| Support Level | $25.78 | $18.74 |
| Resistance Level | $27.97 | $20.27 |
| Average True Range (ATR) | 0.92 | 0.78 |
| MACD | 0.37 | -0.04 |
| Stochastic Oscillator | 68.25 | 55.63 |
Dana Inc is provider of products to virtually every vehicle manufacturer in the world. Its technologies include drive systems (axles, driveshafts and transmissions); electrodynamic technologies (motors, inverters, software and control systems, battery-management systems, and fuel cell plates); sealing solutions (gaskets, seals, cam covers, and oil pan modules); thermal-management technologies (transmission and engine oil cooling, battery and electronics cooling, charge air cooling, and thermal-acoustical protective shielding); and digital solutions (active and passive system controls and descriptive and predictive analytics). The company has two operating segments: Light Vehicle and Commercial Vehicle. The Light Vehicles segment generates the majority of revenue.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.